SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
MD reported Three months ended September 30, 2026 results. The stock moved +0.9% on the print.
MDearnings

Earnings reactions, page 10

Pediatrix Medical Group, Inc. (MD) FY2026 earnings

October 29, 2026 · SharpeIQ Research Desk

Reported results

  • Net revenue of $501 million for the third quarter of 2026.
  • Net income of $47 million for the third quarter of 2026.
  • Adjusted EBITDA of $85 million for the third quarter of 2026.
  • Earnings of $0.59 per share for the third quarter of 2026.
  • Non-GAAP Adjusted EPS of $0.72 for the third quarter of 2026.

Guidance

  • Full year 2026 outlook for Adjusted EBITDA in a range of $290 million to $300 million.

Price and volatility reaction

The stock moved +0.9% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -30.2 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release28.912026-10-28
Close after release29.182026-10-29
Realised move+0.9%close to close
30d ATM IV change-30.2 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →